Eltrombopag Tablet, Film Coated
Product Images NDC 70377-184

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 70377-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Image001)

Eltrombopag Tablets 12.5 mg film-coated oral tablets in a 30-tablet package by Biocon Pharma Inc. The label includes dosage instructions, storage conditions, and a note that the package is child-resistant. It also features a barcode and batch serialization coding area.*

FDA Label Image

Label (Image002)

Packaging label for Eltrombopag Tablets 25 mg, film-coated oral tablets. The label includes handling instructions, dosage guidance referring to accompanying prescribing information, and manufacturer details: Biocon Pharma Inc. The package contains 30 tablets and is marked for prescription use only, with safety and storage information provided.*

FDA Label Image

Label (Image003)

Eltrombopag Tablets 25 mg film-coated tablets label by Biocon Pharma Inc. The label includes dosing instructions to swallow whole and warnings not to split, chew, or crush tablets. Package contains 84 tablets. Manufactured by Aizant Drug Research Solutions in India for Biocon Pharma in New Jersey, USA. Storage instructions specify room temperature between 20°C to 25°C. Includes barcodes and mentions dispensing with a Medication Guide.*

FDA Label Image

Label (Image004)

Eltrombopag Tablets 50 mg film-coated oral tablets packaging label by Biocon Pharma Inc. The carton contains 14 tablets. Instructions on dosage, storage conditions, and safety warnings are included. The label also shows barcodes and manufacturing details, indicating the product is child-resistant and includes a medication guide.*

FDA Label Image

Label (Image005)

Eltrombopag Tablets 50 mg film-coated oral tablets in a package of 30, labeled for Biocon Pharma Inc. The label includes dosage instructions to swallow tablets whole without splitting, chewing, or crushing. It also mentions child-resistant packaging, storage conditions, and a barcode. The strength and labeler details are clearly shown.*

FDA Label Image

Label (Image006)

Label for Eltrombopag Tablets 50 mg film-coated oral tablets. The label states to swallow tablets whole and not to split, chew, or crush them. It includes storage instructions, a warning about the safety seal, and dispensing instructions. The package contains 84 tablets. Manufactured for Biocon Pharma Inc., with manufacturing by Aizant Drug Research Solutions Private Limited in Hyderabad, India. The label includes barcodes and a section reserved for batch serialization coding.*

FDA Label Image

Label (Image007)

Eltrombopag Tablets 75 mg film-coated oral tablets packaging label. The label shows the product name, strength, and instructions to swallow tablets whole without splitting or crushing. It includes manufacturer details: Biocon Pharma Inc., with additional manufacturing info by Aizant Drug Research Solutions in Hyderabad, India. The package contains 30 tablets and is child-resistant with storage instructions.*

FDA Label Image

Label (Image008)

The label for Eltrombopag tablets, 75 mg film-coated tablets, includes storage instructions, a warning not to use if the safety seal is broken, and dosage information referencing the Prescribing Information. The package contains 84 tablets and is labeled Rx Only. It is manufactured by Biocon Pharma Inc., with barcodes and a QR code area for batch serialization.*

FDA Label Image

Carton-25mg-14's (Image009)

Eltrombopag Tablets 25 mg film-coated tablets packaging label by Biocon Pharma Inc. The label includes the strength of 25 mg, quantity of 14 tablets (1x14 unit-dose), and mentions manufacture by Aizant Drug Research Solutions Private Limited, India. It also features storage instructions and a barcode.*

FDA Label Image

Carton-50mg-10's (Image010)

Packaging label for Eltrombopag Tablets 50 mg, film-coated oral tablets. The label shows the product name, strength, and dosage form, with instructions to swallow tablets whole and a note that the product is Rx only. Packaging contains 10 tablets (1x10 unit-dose). Biocon Pharma Inc. is listed as the labeler, with manufacturing by Aizant Drug Research Solutions Private Limited, India. Storage and safety information is also included.*

FDA Label Image

Carton-75mg-10's (Image011)

Packaging label for Eltrombopag Tablets 75 mg oral film-coated tablets by Biocon Pharma Inc. The label indicates a 10-tablet unit-dose pack. It includes storage instructions, manufacturer details (Aizant Drug Research Solutions Private Limited, India), and states the product is for prescription use only.*

FDA Label Image

Eltrombopag Olamine Chemical Structure (Structure)

Chemical structure of eltrombopag olamine, the active ingredient in Eltrombopag tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.